More questions for J&J vaccine boosters ahead of FDA review - Albuquerque Journal

More questions for J&J vaccine boosters ahead of FDA review

WASHINGTON — The Food and Drug Administration is wrestling with whether and when to offer another dose of the single-shot Johnson & Johnson COVID-19 vaccine, while a new study out Wednesday raises the prospect that using a different brand as the booster might work better.

In an online review posted Wednesday, FDA scientists didn’t reach a firm conclusion about whether there’s enough evidence for J&J boosters, citing shortcomings with the company’s data and little information on protection against the extra-contagious delta variant of the coronavirus.

The review comes ahead of meetings Thursday and Friday when an FDA advisory panel will recommend whether to back booster doses of both the J&J and Moderna vaccines. That’s one step in the government’s vaccine review process: Next week, the FDA will make a final decision on authorizing those boosters and then the Centers for Disease Control and Prevention will debate who actually should get them.

Adding to the complexity is whether it’s OK to use a booster that’s a different brand than someone’s initial shots. Preliminary results of a U.S. government study suggest that mixing and matching boosters will work at least as well — and maybe far better for J&J recipients. Those people had a stronger immune response if they got either a Moderna or Pfizer shot as their booster than if they received another dose of the J&J vaccine, according to results posted online Wednesday. Mix-and-match is also up for discussion by the FDA panel this week.

Health authorities say all the vaccines used in the U.S. continue to provide strong protection against severe disease or death from COVID-19. But amid signs that protection against milder infections may be waning, the government already has cleared booster doses of the Pfizer vaccine for certain people starting at six months after their last shot.

Aiming for uniform recommendations, Moderna likewise asked the FDA to clear its booster dose at six months. But J&J complicated the decision by proposing a second shot over a range of two to six months.

FDA reviewers wrote that a study of the two-month booster plan suggests “there may be a benefit,” while pointing to only small numbers of people who got another shot at six months instead.

Overall, the J&J vaccine “still affords protection against severe COVID-19 disease and death,” the FDA’s reviewers concluded. But data about its effectiveness “are consistently less” than the protection seen with Pfizer and Moderna shots.

For its part, J&J filed data with the FDA from a real-world study showing its vaccine remains about 80% effective against hospitalizations in the U.S.

J&J’s single-dose vaccine was highly anticipated for its one-and-done formulation. But its rollout was hurt by a series of troubles including manufacturing problems and some rare but serious side effects including a blood clot disorder and a neurological reaction called Guillain-Barre syndrome. In both cases, regulators decided the shot’s benefits outweighed those risks.

Rival drugmakers Pfizer and Moderna have provided the vast majority of U.S. COVID-19 vaccines. More than 170 million Americans have been fully vaccinated with those companies’ two-dose shots while less than 15 million Americans got the J&J shot.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.


Albuquerque Journal and its reporters are committed to telling the stories of our community.

• Do you have a question you want someone to try to answer for you? Do you have a bright spot you want to share?
   We want to hear from you. Please email yourstory@abqjournal.com

Nativo Sponsored Content

Ad Tango

taboola desktop

MORE ARTICLES LIKE THIS

1
1 killed, 1 injured by prop firearm on Santa ...
ABQnews Seeker
A woman was killed and a ... A woman was killed and a man was injured when they were shot by a prop firearm Thursday afternoon at a movie set outside ...
2
Beautiful day for an old, blind dog
Blogs
A group of cyclists carried the ... A group of cyclists carried the weak, fragile dog down the mountain to safety – and a foster home
3
FBI: Suspect decapitated man, torched head on Navajo Nation
ABQnews Seeker
What goes around, comes around. That’s ... What goes around, comes around. That’s what authorities say a bloodied hitchhiker told his ride hours after he decapitated a man with an ax ...
4
Health officials prepare for rollout of COVID vaccine for ...
ABQnews Seeker
State has pre-ordered 66,000 doses over ... State has pre-ordered 66,000 doses over three waves
5
CYFD probes child's death, reviews procedures
ABQnews Seeker
Aunt says she reported abuse of ... Aunt says she reported abuse of tot, siblings; dad, grandmother charged
6
CYFD to open bids for tech upgrade
ABQnews Seeker
Change follows departure of former Cabinet ... Change follows departure of former Cabinet secretary, who pushed for single vendor
7
Suspect held in monthlong string of robberies
ABQnews Seeker
Bandit apologized to victims in over ... Bandit apologized to victims in over a dozen alleged heists
8
Competency hearing set in school shooting
ABQnews Seeker
13-year-old will be tried as a ... 13-year-old will be tried as a juvenile if he is deemed fit
9
Pecos River set for major water shortages
ABQnews Seeker
Agencies propose repairing infrastructure, removing invasive ... Agencies propose repairing infrastructure, removing invasive plant species
10
Advisory panel endorses redistricting maps for New Mexico
ABQnews Seeker
Lawmakers plan to convene in December ... Lawmakers plan to convene in December to redraw a range of boundaries